HLVX

HilleVax, Inc · NASDAQ

Sector Health Technology
Industry Biotechnology
Website illevax.com
Employees(FY) 62
ISIN US43157M1027

Performance

-9.6%

-4.79%

-4.28%

-88.7%

-88.85%

YTD

-87.11%

Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Advanced Technical Analysis

Technical Analysis of HLVX 2024-11-20

The stock indicators reflect a bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 40 suggesting a neutral stance, and a Technical Score of 25 reinforcing the overall bearish outlook. This combination signals caution for potential investors as the market appears to be under pressure.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of HLVX

Stock Rank

Recent News & Updates

2024-11-06 19:00
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress(Globenewswire)
2024-10-14 00:00
What Makes HilleVax (HLVX) a New Buy Stock(Yahoo Finance)
2024-08-08 07:20
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress(Globenewswire)
2024-07-31 23:53
HilleVax slashes workforce by 40% after norovirus vaccine trial failure(Yahoo Finance)
2024-07-31 04:00
HilleVax Announces Reduction in Force(Globenewswire)
2024-07-28 21:35
After Plunging -86.93% in 4 Weeks, Here's Why the Trend Might Reverse for HilleVax (HLVX)(Yahoo Finance)
2024-07-10 21:35
Down -88.84% in 4 Weeks, Here's Why HilleVax (HLVX) Looks Ripe for a Turnaround(Zacks)
2024-07-08 22:19
HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails(Zacks)
2024-07-08 08:18
HilleVax's Acute Gastroenteritis Vaccines Fails Main Goal in Phase 2 Study; Shares Plunge Premarket(MT Newswires)
2024-07-08 07:30
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants(GlobeNewswire)
2024-07-08 00:36
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest(Investorplace)
2024-07-08 00:17
Why Is HilleVax (HLVX) Stock Down 87% Today?(Investorplace)
2024-07-07 20:42
Takeda-spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants(Fiercebiotech)
2024-07-07 20:16
HilleVaxs norovirus vaccine ineffective in large trial of infants(Yahoo Finance)
2024-07-07 19:30
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants(Globenewswire)
2024-05-24 16:51
Recursion Names HilleVax CEO Robert Hershberg as New Board Chair(MT Newswires)
2024-05-23 02:15
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)(GuruFocus.com)
2024-05-22 17:48
Hillevax Insider Sold Shares Worth $266,291, According to a Recent SEC Filing(MT Newswires)
2024-05-10 14:26
HilleVax Inc (HLVX) Reports Increased Q1 Losses, Misses Analyst Earnings Expectations(GuruFocus.com)
2024-05-09 16:05
HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress(GlobeNewswire)
2024-05-09 11:55
HLVX Stock Earnings: HilleVax Misses EPS for Q1 2024(Investorplace)
2024-05-09 04:05
HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress(Globenewswire)
2024-04-14 12:52
10 Buy-Rated Stocks with Latest Insider Purchases(Insider Monkey)
2024-04-14 00:52
10 Buy-Rated Stocks with Latest Insider Purchases(Insidermonkey)
2024-04-06 01:33
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)(GuruFocus.com)
2024-03-21 02:32
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)(GuruFocus.com)
2024-03-20 16:00
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress(GlobeNewswire)
2024-03-20 09:53
HLVX Stock Earnings: HilleVax Beats EPS for Q4 2023(Investorplace)
2024-03-20 04:00
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress(Globenewswire)
2024-03-08 23:55
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)(GuruFocus.com)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.